<p>The texts are derived from the European Clinical Trial Regulation No.536/2014, and (if necessary) modified for instructional and educational purposes.</p
In view of the impact of the pandemic on European healthcare systems, the European authorities publi...
<p>Safety Reporting Flowchart: Periodic Line Listing, DSUR and Clinical Study Report. The texts are ...
The EU Clinical Trials Directive came into force on 1 May 2004 and has changed the face of Clinical ...
The new Regulation (EU) No. 536/2014 for clinical trials of medicinal products for human is part of ...
For the 28 member states of the European Union, Regulation (EU) No 536/2014 on clinical trials on me...
Introduction: In recent years, a significant decrease in the number of clinical trials was observed ...
New Clinical Trials Regulation EU no 536/2014 (EU CTR) will be implemented fully in European Union i...
The new Regulation (EU) No. 536/2014 for clinical trials of medicinal products for human use will re...
The coming into force of Directive 2001/20/EC represented a step forward in harmonising clinical tri...
AIMS To facilitate and improve clinical research within Europe, the European Union (EU) adopted in 2...
The coming into force of Directive 2001/20/EC represented a step forward in harmonising clinical tri...
The aim of the Round Table was to make recommendations with regard to the imminent revisio...
In May 2014, the European Union Parliament and Council published a new regulation on clini...
The purpose of the clinical trial guidelines is to harmonise legislation in order to ensure consist...
European Union (EU) Clinical Trials Regulation 536/2014, expected to come into force in 2019, provid...
In view of the impact of the pandemic on European healthcare systems, the European authorities publi...
<p>Safety Reporting Flowchart: Periodic Line Listing, DSUR and Clinical Study Report. The texts are ...
The EU Clinical Trials Directive came into force on 1 May 2004 and has changed the face of Clinical ...
The new Regulation (EU) No. 536/2014 for clinical trials of medicinal products for human is part of ...
For the 28 member states of the European Union, Regulation (EU) No 536/2014 on clinical trials on me...
Introduction: In recent years, a significant decrease in the number of clinical trials was observed ...
New Clinical Trials Regulation EU no 536/2014 (EU CTR) will be implemented fully in European Union i...
The new Regulation (EU) No. 536/2014 for clinical trials of medicinal products for human use will re...
The coming into force of Directive 2001/20/EC represented a step forward in harmonising clinical tri...
AIMS To facilitate and improve clinical research within Europe, the European Union (EU) adopted in 2...
The coming into force of Directive 2001/20/EC represented a step forward in harmonising clinical tri...
The aim of the Round Table was to make recommendations with regard to the imminent revisio...
In May 2014, the European Union Parliament and Council published a new regulation on clini...
The purpose of the clinical trial guidelines is to harmonise legislation in order to ensure consist...
European Union (EU) Clinical Trials Regulation 536/2014, expected to come into force in 2019, provid...
In view of the impact of the pandemic on European healthcare systems, the European authorities publi...
<p>Safety Reporting Flowchart: Periodic Line Listing, DSUR and Clinical Study Report. The texts are ...
The EU Clinical Trials Directive came into force on 1 May 2004 and has changed the face of Clinical ...